Outset Medical Reports 14% Revenue Growth in Q3 2026 Driven by Console Sales and Service Expansion
Outset Medical (OM) reported third-quarter revenue of $33.6 million, marking a 14% increase year-over-year. The growth was fueled by a 26% surge in console revenue and steady increases across recurring consumables and service lines. Despite a non-GAAP net loss of $12.9 million, the company demonstrated improved operating leverage, with expenses growing only 4% compared to the double-digit revenue climb. Management highlighted a significant $150 million refresh opportunity involving over 3,000 consoles nearing end-of-life. Looking ahead, Outset Medical reiterated its full-year 2026 revenue guidance of $125 million to $130 million, supported by a strong commercial pipeline and high customer retention rates. While gross margins faced pressure from a higher mix of console sales, service and software integration continue to show robust growth.
Topics: Financial Performance Gross Margin Net Loss Revenue Growth